Found 24 matching trials
A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting N/A This is a multicenter, non-randomized, non-interventional three-cohort stud...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment PHASE3 To evaluate the efficacy of subcutaneous (SC) evolocumab, compared to regul...
Show More Learn More & Join Trial
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children NA Liposorber® LA-15 System is a blood purification therapy that selectively r...
Show More Location
Loma Linda University Children's Hospital
Learn More & Join Trial
Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes N/A This multicenter multinational prospective two-arm matched-pair observation...
Show More Location
University Hospital Carl Gustav Carus
Learn More & Join Trial
(H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol NA The primary objective of the study is to demonstrate that the performance o...
Show More Location
Hartford Hospital
Learn More & Join Trial
Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia N/A Homozygous familial hypercholesterolemia (HoFH) is characterized by a six- ...
Show More Location
Institute of Nutrition and Functional Foods (INAF)
Learn More & Join Trial
Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy PHASE3 The primary objective of the study is to evaluate the effect of alirocumab ...
Show More Location
Multiple Locations
Learn More & Join Trial
Long-term Characterization of Lipoprotein Apheresis Technologies for Individual Device Adaption (LOLIDA) N/A Lipoprotein apheresis is often applied as the final treatment of patient wi...
Show More Location
Carl Gustav Carus University Hospital Dresden, Technische Universität Dresden,
Learn More & Join Trial
Evolocumab Versus LDL Apheresis in Patients With Hypercholesterolemia PHASE3 An open-label, prospective phase III study to compare the efficacy and safe...
Show More Location
Hospital General Universitario Gregorio Marañon
Learn More & Join Trial
Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a) NA Lipoprotein(a) \[Lp(a)\] is an independent risk factor for cardiovascular d...
Show More Location
Lipidambulanz, Interdisziplinäres Stoffwechsel-Centrum, CVK, Charite
Learn More & Join Trial